Pangea Botanica

Pangea Bio

This biotechnology company develops small molecule medicines for neurological and neuropsychiatric disorders using an artificial intelligence platform to identify compounds from natural sources.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.

Delix

This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.

Mindstate Design Labs

This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.

Kasvu Therapeutics

This company develops small-molecule neuroplastogen treatments for neuropsychiatric and neurodegenerative disorders, targeting patients with major depressive disorder and brain diseases.

Sensorium Therapeutics

This biotech company develops central nervous system therapies for patients with anxiety, epilepsy and neurodegenerative diseases using a machine learning drug discovery platform.

Hemispheric

This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.

Mindstate

This pharmaceutical company develops designer psychedelic compounds using artificial intelligence to treat mental health conditions such as treatment-resistant post-traumatic stress disorder.